Clinical Trial Update: Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing cabazitaxel to topotecan for small cell lung cancer has completed. Results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Jevtana (cabazitaxel)
• Topotecan (topotecan)

Snippet

Sponsor: Sanofi | Conditions: Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-04-13